Agenda

September 19, 2024 | Virtual & in-person at UW Tower, Seattle

8:00-9:00am – Registration / Sign-in

9:00-9:15am – Opening Remarks

Susan Ferguson, PhD, Director, UW Addictions, Drug & Alcohol Institute (ADAI)
Beatriz Carlini, PhD, MPH, Director, ADAI Cannabis Research & Education Program (CERP)

9:15-10:15am – Cannabis use and psychosis: Past, present, and future

Moderators: Kristen Haley, BA & Beatriz Carlini, PhD, MPH

Keynote Speaker: Marta Di Forti, MD, PhD*
King’s College of London, United Kingdom

10:15-10:30am – Break

10:30-12:30pm – Reviewing the evidence: Cannabis use, schizophrenia, and psychotic disorders

Moderators: Sarah Okey, PhD & Sharon Garrett, MPH, MA

Cannabis-induced psychosis and schizophrenia following cannabis legalization and commercialization in Canada
Daniel Myran, MD, MPH* (Ottawa Hospital Research Institute, Canada)
Understanding causality between cannabis potency and psychotic experiences through longitudinal cohorts
Lindsey A. Hines, PhD* (University of Bath, UK)
Lived experience testimony video
Gone to pot? The complex relationships between cannabis, cannabinoids and psychosis
Deepak Cyril D’Souza, MD* (Yale University)
Panel Q&A

12:30-1:30pm – Lunch (provided). Lived experience testimony video.

1:30-3:30pm – Promising clinical interventions to reduce cannabis use among at-risk consumers

Moderators: Harrison Fontaine, PhD & Lyndsey Kellum, MEd

Recent advances in novel approaches to reduce cannabis harms among young adults
Jason Kilmer, PhD and Katherine Walukevich-Dienst, PhD (University of Washington)
CannTalk: A brief intervention for discussing cannabis with clients experiencing psychosis.
Denise Walker, PhD (University of Washington)
Lived experience testimony video.
Cannabis interventions to reduce consumption and risk among young adults
Erin Bonar, PhD* (University of Michigan)
Panel Q&A

3:30-3:45pm – Break

3:45-4:15pm – Promising policies to reduce onset and progression of psychotic disorders in U.S. states with legal cannabis markets

Moderators: Marie Gray, MS & Sharon Garrett, MPH, MA

4:15-4:30pm – Closing remarks and final discussion

* denotes virtual presentation